$0.3149
-0.02-7.08%
At close: -
$0.3046
-0.01-3.27%
After Hours: Feb 21, 6:24 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Eterna Therapeutics in recent months.
Browse guidance and forecast on all stocks.